Phosphatidylinositol 3‐kinase signaling pathway and inflammatory bowel disease: Current status and future prospects.Published in:Fundamental & Clinical Pharmacology, 2023, v. 37, n. 5, p. 910, doi. 10.1111/fcp.12894By:Jalil, Abduladheem Turki;Hassan, Neeran Flaeh;Abdulameer, Sada Jasim;Farhan, Zainab Mohammed;Suleiman, Ahmed AbdulJabbar;Al‐Azzawi, Abdul Kareem;Zabibah, Rahman;Fadhil, AliPublication type:Article